Back

Risk stratification of patients with apparently idiopathic premature ventricular contractions: data from a multicenter international cardiac magnetic resonance registry

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: CMR for outcome prediction Late Gadolinium Enhancement ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Gaetano Nucifora

Manchester University NHS Foundation Trust, Manchester (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Tissue tracking by cardiovascular magnetic resonance imaging is associated with outcome in heart failure with preserved ejection fraction
Doctor A. Kammerlander (Vienna, AT)
Abstract
Presentation thumbnail
Vasodilator stress cardiovascular magnetic resonance imaging predicts long-term cardiac death and all-cause death in patients with known or suspected coronary artery disease
Doctor V. Marcos Garces (Valencia, ES)
Abstract Slides
Presentation thumbnail
Lateral mitral annular plane excursion measured using cardiac magnetic resonance imaging is an independent predictor of all cause mortality in patients with hypertension: a multicenter study
Doctor S. Romano (Verona, IT)
Abstract Slides
Presentation thumbnail
Reduction in mortality from implantable cardioverter-defibrillators in non-ischemic cardiomyopathy patients is dependent on the presence of left ventricular scar
Doctor S. Gutman (Melbourne, AU)
Abstract Slides
Presentation thumbnail
Predictive logistic model of inter-ventricular lead distance in cardiac resynchronization therapy
Doctor T. Lubimceva (Saint Petersburg, RU)
Abstract Slides

Access the full session

Session thumbnail
CMR for outcome prediction

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
CMR in acute coronary syndrome: optional or essential? - discussion
thumbnail
Congress Presentation
Late gadolinium enhancement and viability
thumbnail
Congress Presentation
Magnetic resonance imaging is the way to go for risk assessment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources